Market closed

PROCEPT BioRobotics/$PRCT

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About PROCEPT BioRobotics

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.

Ticker

$PRCT

Sector

Health Care

Trading on

NASDAQ

Industry

Health Care Equipment & Supplies

Headquarters

San Jose, United States

Employees

626

Website

www.procept-biorobotics.com

PRCT Metrics

BasicAdvanced

$4.5B

-

-$1.95

1.03 -

Price and volume

Market cap

$4.5B

Beta

1.03

52-week high

$96.70

52-week low

$44.02

Average daily volume

541K

Financial strength

Current ratio

6.021

Quick ratio

4.955

Long term debt to equity

32.667

Total debt to equity

34.259

Interest coverage (TTM)

-24.53%

Management effectiveness

Return on assets (TTM)

-16.73%

Return on equity (TTM)

-37.02%

Valuation

Price to revenue (TTM)

21.291

Price to book

17.92

Price to tangible book (TTM)

Price to free cash flow (TTM)

-41.084

Growth

Revenue change (TTM)

71.71%

Earnings per share change (TTM)

-16.22%

3-year revenue growth (CAGR)

93.56%

3-year earnings per share growth (CAGR)

-38.76%

What the Analysts think about PRCT

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for PROCEPT BioRobotics stock.

PRCT Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

PRCT Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

PRCT News

AllArticlesVideos

PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024

GlobeNewsWire·2 months ago

Procept BioRobotics: Continued Growth Runway Ahead

Seeking Alpha·2 months ago

PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

GlobeNewsWire·3 months ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PRCT

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for PROCEPT BioRobotics stock?

PROCEPT BioRobotics (PRCT) has a market cap of $4.5B as of January 15, 2025.

What is the P/E ratio for PROCEPT BioRobotics stock?

The price to earnings (P/E) ratio for PROCEPT BioRobotics (PRCT) stock is 0 as of January 15, 2025.

Does PROCEPT BioRobotics stock pay dividends?

No, PROCEPT BioRobotics (PRCT) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next PROCEPT BioRobotics dividend payment date?

PROCEPT BioRobotics (PRCT) stock does not pay dividends to its shareholders.

What is the beta indicator for PROCEPT BioRobotics?

PROCEPT BioRobotics (PRCT) has a beta rating of 1.03. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.